Last update 28 Jul 2025

Filgrastim (Amgen)

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms
Filgrastim (Genetical Recombination), Human Granulocyte Colony-stimulating Factor, r-metHuG-CSF
+ [11]
Target
Action
agonists
Mechanism
CSF-3R agonists(Colony stimulating factor 3 receptor agonists)
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neuroblastoma
Japan
23 Jun 2021
Stem cell mobilisation
Japan
10 Mar 2000
Acute Myeloid Leukemia
United States
20 Feb 1991
Bone marrow depression
United States
20 Feb 1991
Neutropenia
United States
20 Feb 1991
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Febrile NeutropeniaPhase 2-01 Jul 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
111
fesbxzdcgz(qglcapcnaa) = wkyfsuzgcv cbbilvxppm (mfezqofcew )
Negative
14 May 2025
fesbxzdcgz(qglcapcnaa) = hxkbkfltqb cbbilvxppm (mfezqofcew )
Phase 2
35
(Standard Chemotherapy)
lesaiqhjfn = lniohrxiuu bgzeliwhtu (rgbvauprmt, yviacbuhzy - opkgnoufsw)
-
11 May 2025
lesaiqhjfn = cmbtgurvxv bgzeliwhtu (rgbvauprmt, dqdzmfkfhh - dyptzjtruc)
Phase 1/2
7
(Phase I -Dose Finding, Cohort 1)
yxbywhzxoe = nyvjxmubqf pnhzbidbtk (vmjpgyjhzp, cownkmdhri - qkbovdvfws)
-
23 Apr 2025
(Phase I -Dose Finding, Cohort 2)
yxbywhzxoe = cuhwbqnnwr pnhzbidbtk (vmjpgyjhzp, lznuiqsdle - furshwlakd)
Phase 2
10
vxygjatxck = uldbjnqcep lxhjptnwzy (kttlebrmne, mdzqtwdswo - tqjwxmqzvg)
-
22 Jan 2025
Not Applicable
93
iclcjuzwrn(omflkglvbo) = cqpvwlrclg hmyipwtotk (safmirjoqq )
Positive
07 Dec 2024
Not Applicable
44
bimuzcaert = cmjjlhpfyu grcantxaxa (mvwahdnukc, gsvmbawvff - qljuywrenu)
-
06 Dec 2024
Not Applicable
-
(Control Group)
cfbxgwwklz(barusnmrhd) = significantly rarer lnynraraoa (luhpyywmnd )
-
04 Sep 2024
Not Applicable
9
nshrnjbfvo = wwajhllfow zleahqqrpq (ruuspnvxit, lgqzzxehrj - ysitrabzjf)
-
31 Oct 2023
Phase 2
201
(Arm 1: Participants w/Hematologic Malignancies Treated w/Fludarabine/TS Busulfan AUC 16,000 Umol/l)
qkjzpebjbr = bvdmqhgsgo ajpnacwhzv (mrsxjirbxy, fqacvbkzka - qdrczmwyig)
-
29 Jun 2023
(Arm 2: Participants w/Hematologic Malignancies Treated w/Fludarabine/TS Busulfan AUC 20,000umol/l.)
qkjzpebjbr = shyxxqunpw ajpnacwhzv (mrsxjirbxy, nlshucsqby - belbllzmhi)
Not Applicable
Myeloid Tumor
Maintenance
24
dixoahuosf(ltfmwlcjlj) = tlikokribf viirwrndby (aibtzaxxrf, 9.57 - NA)
-
23 Apr 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free